The Ledger

Tenet Healthcare raised its 2026 profit outlook by $195 million at the midpoint, and $147 million of its third-quarter beat was timing. The hospital and surgery center operator reported October 29 that third-quarter net operating revenues rose 6.5% to $5.631 billion and adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) rose 23.3% to $1.355 billion, a 24.1% margin against 20.8% a year ago, per its 8-K earnings release. Full-year adjusted EBITDA guidance is now $5.05 billion to $5.20 billion, and adjusted free cash flow $2.825 billion to $3.125 billion. The release says a $97 million timing-related revenue benefit and about $50 million of transition benefits added $147 million to the quarter and do not change full-year expectations for revenue cycle management. Hospital adjusted EBITDA was $818 million against $607 million; ambulatory care was $537 million against $492 million, with a 39.2% margin. Same-hospital admissions rose 2.8% and adjusted admissions 3.2%, but net patient service revenue per adjusted admission rose only 0.2%, with commercial employer strength offset by “unfavorable payer mix due to lower exchange admissions.” Tenet bought back 970,000 shares for $255 million in the quarter and in September refinanced $2.0 billion of notes at 6.250% due 2034. The release also lists $646 million of revenue from contract termination, a line we did not parse further. Who it hits: hospital operators, lenders and surgery center buyers pricing outpatient margins. So what: strip the timing items and the quarter is still strong, but price per admission is flat, which matches what HCA and Universal Health Services reported this week. Confidence: High on the figures (company filing); Med on the size of the guidance raise, because the release does not state the prior range and we derived it from Tenet’s July release.

Community Health Systems swung to a loss as payer mix and acuity missed management’s plan. The rural and mid-size hospital operator reported October 28 after the close that third-quarter net operating revenues fell 10.7% to $2.757 billion from $3.087 billion, mostly because it sold hospitals, per its 8-K earnings release. It lost $86 million, or $0.63 per share, against net income of $130 million a year ago. Adjusted EBITDA fell 25.5% to $280 million, a 10.2% margin against 12.2%. Same-store admissions rose 2.2% and adjusted admissions 3.6%, and same-store revenue rose 3.8%. Chief executive Kevin Hammons said payer mix and acuity “did not develop as expected due to the challenging macro environment.” The company has divested 10 hospitals in 2026, including one on October 1, and ran 59 hospitals as of October 28, down from 70 a year earlier. Cash was $155 million at September 30. Who it hits: lenders and bondholders in the most leveraged hospital capital structure, and rural communities where its hospitals are sold or closed. So what: volume is growing at the facilities it kept, but the earnings base is shrinking faster than the debt. The visible release did not include the guidance tables, so we make no claim on its outlook. Confidence: High on the figures (company filing); Low on guidance, which we did not retrieve.

Four hospital operators, one pattern: more patients, almost no extra revenue per patient. Tenet’s revenue per adjusted admission rose 0.2% (above). Universal Health Services’ acute care revenue per adjusted admission fell 1.7% while admissions rose 4.9%, per its 8-K earnings release. HCA attributed a payer mix shift to patients who lost exchange coverage, in its 8-K earnings release. At Community Health Systems, same-store revenue rose 3.8% on 3.6% more adjusted admissions, which by our arithmetic is about 0.2% more per admission. Who it hits: every operator and lender underwriting 2027 hospital margins. So what: the lever has moved from volume to payer mix, and the enhanced premium tax credit expiration is the common thread each company names or implies. Confidence: High on each company’s own figures; Med on the shared cause, since only Tenet and HCA cite the exchanges in their releases and Community Health Systems cites “macro” conditions.

Humana has told investors its profit target holds, but its reported earnings will differ. In an October 9 8-K the Medicare Advantage insurer affirmed 2026 adjusted earnings per share guidance of at least $9.00 while warning of potential changes to its GAAP (generally accepted accounting principles) guidance from “ongoing value creation and other strategic initiatives,” unquantified. It also said it exceeded its goal of top-quartile 2027 Medicare Advantage Star Ratings and has an investor update scheduled for December 10. Third-quarter results are due November 6 at 6:00 a.m. Eastern, per a Business Wire notice (supplemental). Who it hits: Medicare Advantage plan competitors and the providers contracted with them. So what: the open question is what the strategic initiatives cost, not the adjusted number. Confidence: High on the 8-K content; Med on the date, which we have not confirmed on Humana’s investor site.

THE DEAL SHEET

No new transactions spotted in the last 24 hours.

Scan covered SEC filings, company releases and trade press for October 28 and 29. No new health system bankruptcy, rating action, or FTC or DOJ healthcare merger action dated in the window could be confirmed from a primary source. Earlier deals, listed for reference and not new: HealthSpan Partners and Surgery Partners (October 26, about $5.7 billion); Horizon Blue Cross Blue Shield of New Jersey and Summit Health (reported October 21); Cencora and American Oncology Network (October 21). Frontier scan this run: autism therapy (applied behavior analysis) providers; only spring 2026 items surfaced (a Maryland provider’s May Chapter 11 filing, a reported Bierman Autism Centers sale process), nothing in the window, so no story ran.